Literature DB >> 21360442

Genetic alterations in pulmonary epithelioid hemangioendothelioma and epithelioid angiosarcoma.

Y Cao1, S-M Zou, K-T Zhang, N Lu, Y Liu, L Feng, P Wen, N-J Han, D-M Lin.   

Abstract

Epithelioid hemangioendothelioma (EHE) is a low-to-intermediate-grade vascular tumor that occurs in many organs, and epithelioid angiosarcoma (EA) is a subtype of angiosarcoma that is associated with high-grade malignancy. These two types of tumors have different forms of biological behavior. Pulmonary epithelioid hemangioendothelioma (PEH) and epithelioid angiosarcoma (PEA) are both very rare, and genetic studies on them are extremely limited. We examined and compared the cytogenetic characteristics of these two types of lung tumors in two patients utilizing the Array-Comparative Genomic Hybridization (Array-CGH) method. Considerable differences in the cytogenetic characteristics were observed between the two types of tumors. Small fragment gains (<10 MB) were dominant in PEH, whereas large fragment gains and deletions (>10 MB) were dominant in PEA. Some large fragment alterations, such as gains in chromosomes 19q and 19p, and deletions in chromosomes 9p and 13q, involved over half of a chromosome arm. PEH and PEA showed great cytogenetic differences; therefore, further genetic studies on these two types of tumors are warranted.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21360442     DOI: 10.14670/HH-26.491

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  2 in total

1.  Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomics.

Authors:  Antoine Italiano; Chun-Liang Chen; Rachael Thomas; Matthew Breen; Françoise Bonnet; Nicolas Sevenet; Michel Longy; Robert G Maki; Jean-Michel Coindre; Cristina R Antonescu
Journal:  Cancer       Date:  2012-05-30       Impact factor: 6.860

Review 2.  Vascular bone tumors: a proposal of a classification based on clinicopathological, radiographic and genetic features.

Authors:  Costantino Errani; Daniel Vanel; Marco Gambarotti; Marco Alberghini; Piero Picci; Cesare Faldini
Journal:  Skeletal Radiol       Date:  2012-09-21       Impact factor: 2.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.